期刊文献+

肺表面活性物质治疗新生儿呼吸窘迫综合征疗效分析 被引量:8

Curative Effect Analysis of Pulmonary Surfactant Treating Infants Respiratory Distress Syndrome
下载PDF
导出
摘要 目的探讨肺表面活性物质治疗新生儿呼吸窘迫综合征的疗效。方法将60例新生儿呼吸窘迫征患儿随机分为观察组和对照组,每组各30例,对照组给予保暖、吸痰、吸氧、控制感染、防治出血、机械通气等常规治疗,观察组在常规治疗的基础上应用肺表面活性物质治疗,观察两组患儿的发生率。结果观察组新生儿呼吸窘迫综合征的发生率低于对照组,差异有统计学意义(P<0.05)。结论肺表面活性物质治疗新生儿呼吸窘迫综合征患儿疗效显著,有显著的预防作用并可以减轻病情。 Objective Discuss the curative effect of pulmonary surfactant treating infants respiratory distress syndrome.Methods Divided into two groups stochastically 60 examples with infants respiratory distress syndrome,each group of 30 examples,the control group gives oxygen,control of infection,preventing and controlling hemorrhage,machinery ventilation conventional treatments and so on maintains warmth,attractd phlegm,the observation group applied the pulmonary surfactant,infants treatment in the conventional treatment foundation,observed two groups of trouble formation rates.Results There is statistics significance between two groups of infants respiratory distress syndrome formation rates,the observation group is lower than the control group(P0.05).Conclusion There is remarkable prevention function of pulmonary surfactant treating infants respiratory distress syndrome,and may reduce the condition.
作者 靳玉红
出处 《实用心脑肺血管病杂志》 2011年第12期2025-2026,共2页 Practical Journal of Cardiac Cerebral Pneumal and Vascular Disease
关键词 肺泡表面活性剂 呼吸窘迫综合征 新生儿 Pulmonary surfactant Respiratory distress syndrome infants
  • 相关文献

参考文献4

二级参考文献12

共引文献79

同被引文献78

  • 1谢俊刚,徐永健,张珍祥,倪望,陈仕新.肺泡表面活性物质相关蛋白A基因多态性与慢性阻塞性肺疾病易感性的关系[J].中华医学遗传学杂志,2005,22(1):91-93. 被引量:18
  • 2钱新宏,张国成,许东亮.肺炎支原体快速鉴定培养基在儿童支原体感染快速诊断中的应用[J].现代检验医学杂志,2006,21(5):71-72. 被引量:32
  • 3沈晓明,王卫平.儿科学[M].北京:人民卫生出版社,2008:199.
  • 4邵肖梅,叶鸿瑶,丘小汕.实用新生儿学[M].4版.北京:人民卫生出版社,2011:807-808.
  • 5Strayer DS, Pinder R, Chander A. Receptor - mediated regulation of pulmonary surfactant secretion [J]. Exp Cell Res, 1996, 226 (1) : 90 - 97.
  • 6Borron P, Veldhuizen RA, Lewis JF, et al. Surfactant associated protein - A inhibits human lymphocyte proliferation and IL - 2 produc- tion [J. Am J Respir Cell Mol Biol, 2006, 15 (1) : 115 -121.
  • 7Hall - Stoodley L, Watts G, Crowther JE, et al. Mycobactefium tu- berculosis binding to human surfactant proteins A and D, fibronectin and small airway epithelial cells under shear conditions [ J ]. Infect Immun, 2006, 74 (6): 3587-3596.
  • 8金汉珍.实用新生学(第3版)[M].北京:人民卫生出版社,2001:421.
  • 9Wirbelauer J, Thomas W, Speer CP. Preterm and term infants with acute respiratory distress syndrome (ARDS) : what is the role of surfactant substitution? [J] . Z Geburtshilfe Neonatol, 2009, 213 (2): 33-41.
  • 10Cogo PE, Facco M, Simonato M, et al. Dosing of procine sur- factant: effect on kinetics and gas exchange in respiratory dis- tress syndrome [J] . Pediatrics, 2009, 124 (5): e950- e957.

二级引证文献144

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部